Variant report
Variant | esv3380895 |
---|---|
Chromosome Location | chr11:45473822-45474393 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141150249 | chr11:45473829-45473830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs56713024 | chr11:45473837-45473838 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs572920468 | chr11:45473851-45473852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371723997 | chr11:45473852-45473853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376303966 | chr11:45473880-45473881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56214946 | chr11:45473897-45473898 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs560334130 | chr11:45473922-45473923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368418631 | chr11:45473930-45473931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577174207 | chr11:45474016-45474017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189153216 | chr11:45474021-45474022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563015757 | chr11:45474031-45474032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531915047 | chr11:45474033-45474034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548827910 | chr11:45474036-45474037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182548646 | chr11:45474056-45474057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs149472147 | chr11:45474059-45474060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562068034 | chr11:45474063-45474064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548072804 | chr11:45474106-45474107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143951496 | chr11:45474151-45474152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114787964 | chr11:45474158-45474159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551956454 | chr11:45474175-45474176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs185392620 | chr11:45474218-45474219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138447164 | chr11:45474219-45474220 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs554382110 | chr11:45474245-45474246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568013351 | chr11:45474275-45474276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533793534 | chr11:45474295-45474296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545063000 | chr11:45474320-45474321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558632591 | chr11:45474342-45474343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Parathyroid adenoma | 22454399 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Melanoma | 18172304 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Potocki-Shaffer syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 16608533 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:45466600-45474200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr11:45472200-45477000 | Weak transcription | Right Atrium | heart |
3 | chr11:45472400-45474000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr11:45473600-45478600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr11:45474200-45474400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |